Your browser doesn't support javascript.
loading
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
Baldwin, Susan L; Reese, Valerie A; Larsen, Sasha E; Beebe, Elyse; Guderian, Jeff; Orr, Mark T; Fox, Christopher B; Reed, Steven G; Coler, Rhea N.
Afiliação
  • Baldwin SL; Seattle Children's Research Institute, Seattle, WA, United States of America.
  • Reese VA; Seattle Children's Research Institute, Seattle, WA, United States of America.
  • Larsen SE; Seattle Children's Research Institute, Seattle, WA, United States of America.
  • Beebe E; Infectious Disease Research Institute, Seattle, WA, United States of America.
  • Guderian J; Infectious Disease Research Institute, Seattle, WA, United States of America.
  • Orr MT; Infectious Disease Research Institute, Seattle, WA, United States of America.
  • Fox CB; Infectious Disease Research Institute, Seattle, WA, United States of America.
  • Reed SG; Department of Global Health, University of Washington, Seattle, WA, United States of America.
  • Coler RN; Infectious Disease Research Institute, Seattle, WA, United States of America.
PLoS One ; 16(3): e0247990, 2021.
Article em En | MEDLINE | ID: mdl-33705411
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Vacinas contra a Tuberculose / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Vacinas contra a Tuberculose / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2021 Tipo de documento: Article